Hematological Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Imaging of Neurologic Complications in Hematological Disorders, An Issue of Hematology/Oncology Clinics of North ... - satPRnews (press release)



Imaging of Neurologic Complications in Hematological Disorders, An Issue of Hematology/Oncology Clinics of North ... 
satPRnews (press release)
The Imaging of Neurologic Complications in Hematological Disorders, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 30-4 Report has been published. It provides updated in 2018 year analysis of industries from ...

and more » 


Neutropenia ? Pipeline Review, H2 2017 - MilTech



MilTech
 
Neutropenia ? Pipeline Review, H2 2017 
MilTech
The latest Pharmaceutical and Healthcare latest pipeline guide Neutropenia ? Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Neutropenia (Hematological Disorders), complete with analysis by stage ...

and more » 


Peptide Based Hematological Disorders Therapeutics Industry Best Market Trends and Useful Forecast Estimation till ... - Newsient (blog)



Peptide Based Hematological Disorders Therapeutics Industry Best Market Trends and Useful Forecast Estimation till ... 
Newsient (blog)
Haematological disorders are the disorders related to problems in blood and blood components such as red blood cells, white blood cells, platelets, blood vessels, lymph nodes, spleen, bone marrow and the problems related to the proteins involved in ...

and more » 


Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation - PR Newswire (press release)



Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation 
PR Newswire (press release)
The most frequently used cells are hematopoietic stem cells (HSC) due to their capability to reproduce the entire blood system in blood cancer and hematological disorders. Mesenchymal stem cells, which have the capability to differentiate to a large ...

and more » 


Drugs and Diagnostics for Hematological Disorders: Global Markets - MilTech



Drugs and Diagnostics for Hematological Disorders: Global Markets 
MilTech
The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020. This report provides: ? An overview of the global market for ...

and more » 


Hematological Disorders Diagnostic and Therapeutic Market to Register Unwavering Growth by 2021 - satPRnews (press release)



Hematological Disorders Diagnostic and Therapeutic Market to Register Unwavering Growth by 2021 
satPRnews (press release)
Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes ...
Hematology Diagnostics Market Progresses for Huge Profits During 2023 Edition Truth

all 3 news articles » 


Blood patient's $3-million donation pumps life into hematology unit at University hospital - Edmonton Journal



Edmonton Journal
 
Blood patient's $3-million donation pumps life into hematology unit at University hospital 
Edmonton Journal
The hematology program manages about 500 patients a year from across western and northern Canada for a variety of hematological diseases, including leukemia, lymphomas and a variety of bone marrow failure disorders including aplastic anemia. The ...

 


Rigel Pharmaceuticals (NASDAQ:RIGL) Receives Overweight Rating from Piper Jaffray Companies - The Ledger Gazette



The Lincolnian Online
 
Rigel Pharmaceuticals (NASDAQ:RIGL) Receives Overweight Rating from Piper Jaffray Companies 
The Ledger Gazette
Rigel Pharmaceuticals, Inc. logo Piper Jaffray Companies reissued their overweight rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL) in a report published on Thursday, December 21st, Marketbeat reports. They currently have a $6.00 price objective ...
Rigel Pharmaceuticals (RIGL) Earns Media Impact Score of 0.20 The Lincolnian Online
Rigel Pharmaceuticals (RIGL) Rating Reiterated by Piper Jaffray Companies Dispatch Tribunal
Contrasting Rigel Pharmaceuticals (RIGL) and Tocagen (TOCA) TrueBlueTribune
Week Herald  -Zacks Investment Research  -SEC.gov 
all 29 news articles » 


Aplastic Anemia ? Pipeline Review, H2 2017 - satPRnews (press release)



Aplastic Anemia ? Pipeline Review, H2 2017 
satPRnews (press release)
Aplastic Anemia (Hematological Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive ...

and more » 


Pluristem's PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study - GlobeNewswire (press release)



Pluristem's PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study 
GlobeNewswire (press release)
Our PLX cell products release a range of therapeutic proteins in response to inflammation, ischemia, muscle trauma, hematological disorders, and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion ...

and more »